P-007: HYDROXYUREA FOR THE MANAGEMENT OF SICKLE CELL DISEASE IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW (2000–2022)

por L., TSHILOLO, K., MARFO, F., ADISON, S., KHAN, V., PAINTSIL
Publicado 2022

P-009: IDENTIFYING BARRIERS FOR PATIENTS WITH SICKLE CELL DISEASE TO ACCESS TREATMENT WITH HYDROXYUREA – A QUALITATIVE ANALYSIS OF THE SUPPLY CHAIN IN GHANA

por S., GRAVEN, K., MARFO, A., KARIM, A., BISCHOF, A., GEISSLER
Publicado 2022

P-003: EVALUATION OF TREATMENT PATTERN, HEALTHCARE RESOURCE UTILIZATION AND COSTS OF ILLNESS FOR SICKLE CELL DISEASE IN GHANA: A PRIVATE MEDICAL INSURANCE CLAIMS DATABASE STUDY

por Y., DEI-ADOMAKOH, C., SEGBEFIA, D., DWOMOH, K., MARFO, A., EDGAL, O., EGBUJO, K., ATAGA
Publicado 2022